Compare BIO & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | XPEV |
|---|---|---|
| Founded | 1952 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Auto Manufacturing |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 20.2B |
| IPO Year | N/A | 2020 |
| Metric | BIO | XPEV |
|---|---|---|
| Price | $303.12 | $20.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $358.50 | $24.90 |
| AVG Volume (30 Days) | 156.8K | ★ 8.5M |
| Earning Date | 02-12-2026 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,557,500,000.00 | ★ $9,912,782,208.00 |
| Revenue This Year | $1.62 | $95.09 |
| Revenue Next Year | $2.26 | $38.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 86.64 |
| 52 Week Low | $211.43 | $11.14 |
| 52 Week High | $373.69 | $28.24 |
| Indicator | BIO | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 49.90 |
| Support Level | $298.78 | $19.24 |
| Resistance Level | $305.62 | $21.97 |
| Average True Range (ATR) | 7.17 | 0.60 |
| MACD | -0.15 | 0.31 |
| Stochastic Oscillator | 33.10 | 59.95 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.